Optimum concentration–response curve metrics for supervised selection of discriminative cellular phenotypic endpoints for chemical hazard assessment-Reference-Cited by-同舟云学术

Optimum concentration–response curve metrics for supervised selection of discriminative cellular phenotypic endpoints for chemical hazard assessment

Published:2020-06-29 Issue:9 Volume:94 Page:2951-2964
ISSN:0340-5761
Container-title:Archives of Toxicology
language:en
Short-container-title:Arch Toxicol

Author:

Miller James Alastair,Loo Lit-Hsin^ORCID

Funder

Agency for Science, Technology and Research

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Toxicology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00204-020-02813-3.pdf

Reference40 articles.

1. Bougen-Zhukov N, Loh SY, Lee HK, Loo L-H (2017) Large-scale image-based screening and profiling of cellular phenotypes. Cytometry A 91:115–125. https://doi.org/10.1002/cyto.a.22909

2. Calhelha RC, Martinez MA, Prieto MA, Ferreira ICFR (2017) Mathematical models of cytotoxic effects in endpoint tumor cell line assays: critical assessment of the application of a single parametric value as a standard criterion to quantify the dose–response effects and new unexplored proposal formats. Analyst 142:4124–4141. https://doi.org/10.1039/c7an00782e

3. Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20:273–297. https://doi.org/10.1007/BF00994018

4. Delp J, Funke M, Leist M (2019) Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants. Naunyn Schmiedebergs Arch Pharmacol 392:S4–S4

5. Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A et al (2008) Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol 38:13–71. https://doi.org/10.1080/10408440701669959

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Testing of Chronic ICA-1S Exposure: A Potent Protein Kinase C-ι Inhibitor as a Potential Carcinoma Therapeutic;Drugs and Drug Candidates;2024-05-07